| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |